Volkan Tasdemir

Volkan Tasdemir

Auto-generated profile, based on publicly available information

Volkan Tasdemir

Departments of Neurology and Clinical Neurophysiology, Istanbul Faculty of Medicine Istanbul University Istanbul Turkey

Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
23 April 2017 in Clinical Eeg and Neuroscience
Verified
Journal Article
Closed access
EOEmel Oguz-Akarsu
Emel Oguz-Akarsu
FBFirdevs Dinçsoy Bir
Firdevs Dinçsoy Bir
CBCan Baykal
Can Baykal
VTVolkan Taşdemir
Volkan Taşdemir
BKBülent Kara
Bülent Kara
BBBetül Baykan
Betül Baykan
Lipoid proteinosis (LP) is a rare autosomal recessive disease characterized by deposition of hyaline material in skin and mucosae. Epilepsy, as an extracutaneous manifestation associated with typical mesial temporal calcifications, has already been identified, but its characteristics and long-term prognosis have not been thoroughly investigated. We included 7 consecutive patients with LP with typical intracranial calcifications out of 16 patients with ECM1 mutations and investigated the semiologic features, ictal and interictal EEG findings, and long-term prognosis of epilepsy in this genodermatosis. Four of them had seizures (57.1%), and focal seizures with motionless staring were the most common seizure phenotype, originating from bilateral mesial temporal areas, but interictal spikes were scant. Auras were observed in three patients, mostly as epigastric sensation and déjà vu, which indicated mesial temporal lobe origin. Three patients with homozygous mutations in sixth and seventh exons of the ECM1 gene had a drug-resistant course at the end of long-term follow-up. Molecular genetic testing showed a rare compound heterozygous mutation in one patient, which was also associated with seizures but without drug-resistance. Our findings indicated a spectrum for epilepsy with a desperate drug-resistant course for decades in most patients with LP, which is still an underrecognized disease by neurologists.

30 January 2024 in Journal of the Peripheral Nervous System
Verified
Journal Article
Open access
VTVolkan Tasdemir
Volkan Tasdemir
NSNermin Gorkem Sirin
Nermin Gorkem Sirin
ACArman Cakar
Arman Cakar
ACAyla Culha
Ayla Culha
ASAysun Soysal
Aysun Soysal
AOAli Emre Oge
Ali Emre Oge
Background and Aims: This study aimed to identify the clinical characteristics and electrodiagnostic subtypes of Guillain‐Barré syndrome (GBS) in Istanbul.Methods: Patients with GBS were prospectively recruited between April 2019 and March 2022 and two electrodiagnostic examinations were performed on each patient. The criteria of Ho et al., Hadden et al., Rajabally et al., and Uncini et al. were compared for the differentiation of demyelinating and axonal subtypes, and their relations with anti‐ganglioside antibodies were analyzed.Results: One hundred seventy‐seven patients were included, 69 before the coronavirus disease 2019 pandemic (April 2019–February 2020) and 108 during the pandemic (March 2020–March 2022), without substantial changes in monthly frequencies. As compared with the criteria of Uncini et al., demyelinating GBS subtype diagnosis was more frequent according to the Ho et al. and Hadden et al. criteria (95/162, 58.6% vs. 110/174, 63.2% and 121/174, 69.5%, respectively), and less frequent according to Rajabally et al.'s criteria (76/174, 43.7%). Fourteen patients' diagnoses made using Rajabally et al.'s criteria were shifted to the other subtype with the second electrodiagnostic examination. Of the 106 analyzed patients, 22 had immunoglobulin G anti‐ganglioside antibodies (14 with the axonal subtype). They had less frequent sensory symptoms (54.5% vs. 83.1%, p = 0.009), a more frequent history of previous gastroenteritis (54.5% vs. 22.9%, p = 0.007), and a more severe disease as compared with those without antibodies.Interpretation: Serial electrodiagnostic examinations are more helpful for accurate subtype diagnosis of GBS because of the dynamic pathophysiology of the disease. We observed no significant increase in GBS frequency during the pandemic in this metropolis.

1 January 2026 in Ideggyogyaszati Szemle
Verified
Journal Article
Closed access
VTVolkan Tasdemir
Volkan Tasdemir
NSNermin Gorkem Sirin
Nermin Gorkem Sirin
AOAli Emre Oge
Ali Emre Oge
EOElif Kocasoy Orhan
Elif Kocasoy Orhan
Background and purpose Phrenic nerve conduction studies, including comprehensive recording of compound muscle action potentials (CMAP) from all regions of the dia­ phragm, can be useful in both neurolo­gical conditions affecting the phrenic nerve or diaphragm and non-neurological conditions such as COPD and GERD, and may have potential diagnostic value. It was aimed (a) to determine the most convenient stimulation and recording sites for phrenic nerve conduction studies (NCS), (b) to record CMAPs reflecting the activity of the posterior part of the diaphragm with surface recording electrodes, (c) to define normative values for these studies. Methods Sixty-three healthy subjects were included in the study and CMAPs were recorded simultaneously with two anterior and two posterior electrode derivations while stimulating the phrenic nerve behind the sternocleidomastoid muscle. Results Among the four different electrode placements, the recording electrode pairs providing the highest amplitude CMAPs were those placed 5 cm above the xiphoid process (active) and 16 cm laterally on the costal margin (reference). With this placement method, the upper limit of CMAP latency was 7.70 ms, the lower limit of base-topeak amplitude was 0.30 mV and the lower limit of peak-to-peak amplitude was 0.45 mV. Diaphragmatic CMAPs have been obtained from the majority of volunteers with surface electrodes placed in the posterior regions of the diaphragm, albeit with lower amplitude. Age is the only independent factor affecting the CMAP latency in this study. Conclusion Normative values with the best recording sites for phrenic NCSs were determined. The posterior aspect of the diaphragm could be recorded with surface electrodes despite the lower amplitude and reliability compared to the anterior part.

11 March 2025 in Journal Of Clinical Neurophysiology
Verified
Journal Article
Closed access
VTVolkan Tasdemir
Volkan Tasdemir
NSNermin G. Sirin
Nermin G. Sirin
AOAli E. Oge
Ali E. Oge
OGOn behalf of GBS Istanbul Study Group
On behalf of GBS Istanbul Study Group

18 September 2026 in Movement Disorders
Verified
Journal Article
Open access
BGBronwyn E. Grinton
Bronwyn E. Grinton
CEColin A. Ellis
Colin A. Ellis
MPMered Parnes
Mered Parnes
LSLaina Lusk Stripe
Laina Lusk Stripe
JMJacob E. Munro
Jacob E. Munro
KOKaren L. Oliver
Karen L. Oliver
Background: SLC7A6OS c.191A>G is a rare, autosomal recessive cause of progressive myoclonus epilepsy (PME). The c.191A>G variant, first discovered in two families from Türkiye and Portugal, was recently identified in three additional probands from the USA, all of Puerto Rican ancestry. Objectives: We sought to refine the SLC7A6OS ‐PME phenotype and determine whether all families inherited the variant from the same common ancestor. Methods: Clinical and genotyping data were obtained from all five families. Haplotype analysis using single nucleotide polymorphism arrays to investigate a possible common ancestor was performed. Results: Shared haplotypes suggest all five families inherited the SLC7A6OS variant from a common ancestor approximately 1100 years ago. Subsequent dating estimates were consistent with migration patterns between the eastern Mediterranean, Iberia, and Puerto Rico. Conclusions: Our findings strengthen the previous evidence for SLC7A6OS as a cause of PME and highlight a founder effect in regions with migratory links to Iberia. © 2026 The Author(s). Movement Disorders published by Wiley Periodicals LLC on behalf of International Parkinson and Movement Disorder Society.

2 June 2026 in Journal of the Peripheral Nervous System
Verified
Journal Article
Open access
VTVolkan Tasdemir
Volkan Tasdemir
NSNermin Gorkem Sirin
Nermin Gorkem Sirin
SBSezin Alpaydın Baslo
Sezin Alpaydın Baslo
DADilek Atakli
Dilek Atakli
ASAysun Soysal
Aysun Soysal
EOElif Kocasoy Orhan
Elif Kocasoy Orhan
Background and Aims: To determine the role of phrenic nerve conduction studies (NCS) in identifying subtypes of Guillain‐Barré syndrome (GBS) and to investigate the correlations between phrenic NCS and clinical and respiratory scores. Methods: A clinical evaluation was conducted on 23 patients diagnosed with GBS, encompassing the Medical Research Council (MRC) sum scores, GBS disability scores, and Erasmus GBS Respiratory Insufficiency Scores (EGRIS). Electrodiagnostic studies (EDX) were conducted twice and bilateral phrenic NCSs once within the 6 weeks after symptom onset. The latency, peak‐to‐peak amplitude, and negative peak area of phrenic compound muscle action potential (CMAP) elicited using surface electrodes were measured, and the values indicating prolonged latency (≥ 110%–130% of upper limit of normal (ULN)) and/or prolonged negative peak duration (≥ 130% of ULN) were considered as demyelinating. Results: Phrenic NCSs revealed 87.0% sensitivity and 89.5% specificity in the diagnosis of demyelinating subtype (cut‐off value of latency 8.6 ms). Most of the phrenic CMAP parameters revealed moderate correlations with clinical scores and with the results of median and ulnar EDX studies. Interpretation: Besides its importance for having correlations with clinical and respiratory features, phrenic NCS may improve the diagnostic sensitivity in differentiating GBS subtypes.